Early thoracic surgery consultation and location of therapy impact time to esophagectomy

Neoadjuvant chemoradiation therapy (nCRT) followed by esophagectomy is the standard treatment for resectable, locally advanced esophageal cancer. The ideal timing between neoadjuvant therapy and esophagectomy is unclear. Delayed esophagectomy is associated with worse outcomes. We investigated which...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of thoracic disease Vol. 16; no. 9; pp. 5615 - 5623
Main Authors:	Deeb, Ashley L, Dezube, Aaron R, Lozano, Antonio, Singh, Anupama, De Leon, Luis E, Kucukak, Suden, Jaklitsch, Michael T, Wee, Jon O
Format:	Journal Article
Language:	English
Published:	China AME Publishing Company 30-09-2024
Subjects:	Original CROSS trimodality therapy delayed esophagectomy esophageal cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Neoadjuvant chemoradiation therapy (nCRT) followed by esophagectomy is the standard treatment for resectable, locally advanced esophageal cancer. The ideal timing between neoadjuvant therapy and esophagectomy is unclear. Delayed esophagectomy is associated with worse outcomes. We investigated which factors impacted time to esophagectomy in our patients. We conducted a retrospective analysis of prospectively collected data of patients with pT0-3N0-2 esophageal cancers who underwent CROSS trimodality therapy from May 2016 to January 2020. Sociodemographic factors, comorbidities, and neoadjuvant factors (location of CRT, treatment toxicity, discontinuation of treatment) were compared between patients who underwent surgery within 60 days and those after 60 days. In total, 197 patients were analyzed of whom 137 underwent esophagectomy within 60 days (early surgery, ES) and 60 were outside that window (delayed surgery, DS). More DS patients had a history of myocardial infarction (MI) or stroke (both 11.67% 3.65%, P=0.05) and required CRT dose reduction (16.67% 6.57%, P=0.04). Fewer DS patients received CRT at Dana-Farber Cancer Institute (DFCI) or a DFCI satellite site (33.33% 58.4%, P=0.01) and saw our surgeons before CRT completion (68.33% 89.78%, P=0.001). CRT at DFCI [odds ratio (OR) 2.63, P=0.01] or a satellite site (OR 3.07, P=0.01) and evaluation by a thoracic surgeon (OR 4.07, P=0.001) shortened time to esophagectomy. History of MI (OR 0.29, P=0.04), stroke (OR 0.29, P=0.04), and CRT dose reduction (OR 0.35, P=0.03) delayed time to esophagectomy. Improving access to multispecialty cancer centers and increasing satellite sites may improve time to esophagectomy.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Contributions: (I) Conception and design: AL Deeb, AR Dezube, LE De Leon, S Kucukak, MT Jaklitsch, JO Wee; (II) Administrative support: MT Jaklitsch, JO Wee; (III) Provision of study materials or patients: AL Deeb, A Singh, LE De Leon, S Kucukak; (IV) Collection and assembly of data: A Lozano, A Singh; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
ISSN:	2072-1439 2077-6624
DOI:	10.21037/jtd-24-316